Thiazolylpyrazoline derivatives were recently reported as potent anticancer agents. In this study, novel 1,4-phenylene-bis-N-thiocarbamoylpyrazoles (3a-h and 1,4-phenylene-bis-pyrazolylthiazoles (5a-h were prepared and screened for their anticancer activities against C6 (rat brain tumor cells) and HeLa (human uterus carcinoma). Anticancer activity studies were performed as a dose-dependent assay starting with eight concentrations. 5-Fluorouracil (5-FU) was used as a positive control. Compounds 3c, 3d, and 3h were examined and they revealed almost the same activities compared with 5-FU in terms of cell selectivity against C6 cells. Moreover, compounds 3a-h had lower cytotoxicity than 5-FU. The low cytotoxicity values of 3a-h as well as their high antiproliferative activity were encouraging, but further studies are required on the use of these molecules as anticancer drugs.
Bis-chalcone, bis-N-thiocarbamoylpyrazole, bis-pyrazolylthiazole, HeLa, C6, anticancer activity, cytotoxicity
GÜRDERE, MELİHA BURCU; KAMO, ERDOĞAN; BUDAK, YAKUP; YAĞLIOĞLU, AYŞE ŞAHİN; and CEYLAN, MUSTAFA
"Synthesis and anticancer and cytotoxic effects of novel 1,4-phenylene-bis-N-thiocarbamoylpyrazole and 1,4-phenylene-bis-pyrazolylthiazole derivatives,"
Turkish Journal of Chemistry: Vol. 41:
2, Article 2.
Available at: https://journals.tubitak.gov.tr/chem/vol41/iss2/2